Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different subanesthetic doses of esketamine combined with propofol for painless gastrointestinal endoscopy
ChiCTR2300076647Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- May 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine, propofol and sufentanil in procedural sedation and analgesia (PSA) (4 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoints: Heart rate, Blood pressure and 3 more. Planned start May 2023; status: not yet recruiting.
02
Drugs
esketaminepropofolsufentanil
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on ChiCTR2300076647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076647.